Metformin Hydrochloride Morningside Healthcare (Metformin Hydrochloride)

Metformin Hydrochloride is a biguanide used to manage disorders related to impaired glucose regulation.

• Type 2 diabetes mellitus: improves glycemic control and reduces hepatic glucose output.
• Prediabetes: helps delay progression to overt diabetes by enhancing insulin sensitivity.
• Polycystic ovary syndrome: reduces insulin resistance and may improve menstrual regularity.

• Metformin Hydrochloride lowers blood glucose primarily by inhibiting hepatic gluconeogenesis, decreasing intestinal glucose absorption, and increasing peripheral glucose uptake through activation of AMP‑activated protein kinase (AMPK), which enhances insulin sensitivity in muscle and adipose tissue.

Metformin Hydrochloride may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

• Gastrointestinal upset: nausea, abdominal discomfort, or loss of appetite.
• Diarrhea: frequent loose stools, especially during treatment initiation.
• Metallic taste: transient alteration of taste perception.
• Vitamin B12 deficiency: reduced absorption with long‑term use.

Serious or Rare Side Effects

• Lactic acidosis: a rare but life‑threatening metabolic disturbance.
• Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Hepatic dysfunction: elevated liver enzymes or hepatitis.
• Hypoglycemia: uncommon when used alone but possible with other glucose‑lowering agents.

Before initiating Metformin Hydrochloride, several safety considerations should be reviewed.

• Renal function assessment: ensure adequate kidney function to avoid accumulation.
• Hepatic status evaluation: monitor liver disease as it may increase risk of lactic acidosis.
• Contraindication check: avoid in patients with known hypersensitivity to biguanides.
• Concomitant medication review: assess for drugs that may increase risk of lactic acidosis.
• Patient education: inform about signs of lactic acidosis such as unexplained fatigue or rapid breathing.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Metformin Hydrochloride can interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid)

• Iodinated contrast agents: may precipitate acute renal failure and lactic acidosis.
• Alcohol: potentiates the risk of lactic acidosis.
• Cimetidine: can increase metformin plasma concentrations.

Moderate Interactions (Monitor Closely)

• Beta‑blockers: may mask hypoglycemia symptoms.
• ACE inhibitors or ARBs: monitor renal function and potassium levels.
• Sulfonylureas: increased risk of hypoglycemia when combined.
• Warfarin: may require more frequent INR monitoring.